As reported, the balloon of a 6/7f mynxgrip vascular closure device (vcd) ruptured.There was no reported patient injury.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.The device will be returned for evaluation.
|
Complaint conclusion: as reported, the balloon of a 6f/7f mynxgrip vascular closure device (vcd) ruptured.There was no reported patient injury.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.A non-sterile 6f/7f mynxgrip vascular closure device involved in the reported complaint was returned for investigation.Visual inspection of the device showed that the shuttle was not engaged to the black handle.The syringe and sheath used in the procedure were not returned with the device for the evaluation.The sealant and advancer tube were not returned; therefore, the conditions observed led the investigator to infer that the deployment mechanism was completed during the interventional procedure when the device was used.Functional testing was executed using a cordis lab syringe, and the balloon could not be inflated as a leak was observed in the balloon body.A microscopic analysis was performed to the balloon to confirm the state of the surface and body.During the analysis, it was observed that a longitudinal tear was present at the balloon¿s surface.This tear was concluded to be attributable to the balloon loss of pressure event reported, which was identified as a leak issue in the balloon during the inflation mechanism test.The reported event of ¿balloon-balloon loss of pressure¿ was confirmed through analysis of the returned device.However, the exact cause of the longitudinal tear found could not be conclusively determined during analysis.Based on the information available for review and product analysis, access site vessel characteristics (although not provided) and/or concomitant device factors (although not returned) most likely contributed to the reported event since this type of tear is typically observed when the balloon comes into contact with calcification and/or other procedural devices (such as a damaged procedural sheath, stent or vascular graft).According to the instructions for use (ifu), which is not intended as a mitigation, ¿the safety and effectiveness of mynxgrip have not been established in the following patient populations: patients with clinically significant peripheral vascular disease in the vicinity of the puncture.¿ also stated in the ifu during product preparation, ¿confirm via femoral arteriogram or venogram: common femoral artery or vein single wall puncture.Evidence of adequate flow.There is no evidence of significant pvd in the vicinity of the puncture.¿ additionally, the ifu instructs users to discard the device if the balloon does not maintain pressure.Neither the product analysis, nor the information available for review, suggest that the reported failure could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
|